Home
Mail
TV
News
Sport
Finance
Lifestyle
Entertainment
Weather
Mobile
Yahoo
Mail
Cost Of Living
Watchlists
My Portfolios
Markets
Money
Work
Technology
Industries
Give Feedback
Australia markets closed
ALL ORDS
7,837.40
-100.10
(-1.26%)
ASX 200
7,575.90
-107.10
(-1.39%)
AUD/USD
0.6535
+0.0012
(+0.18%)
OIL
83.66
+0.09
(+0.11%)
GOLD
2,349.60
+7.10
(+0.30%)
Bitcoin AUD
97,475.08
+1,160.66
(+1.21%)
Allogene Therapeutics, Inc. (ALLO)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.8900
+0.0350
(+1.23%)
At close: 04:00PM EDT
2.9199
+0.03
(+1.03%)
After hours:
06:34PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
95
95
156
114,089
0
Operating expenses
Research development
242,914
242,914
256,387
220,176
192,987
Selling general and administrative
71,673
71,673
79,305
74,105
65,256
Total operating expenses
314,587
314,587
335,692
294,281
258,243
Operating income or loss
-314,492
-314,492
-335,536
-180,192
-258,243
Interest expense
-
-
-
-
0
Total other income/expenses net
-31,080
-31,080
-9,444
-3,573
-67,302
Income before tax
-327,265
-327,265
-340,414
-182,051
-316,381
Income tax expense
-
-
-
0
0
Income from continuing operations
-327,265
-327,265
-340,414
-182,051
-316,381
Net income
-327,265
-327,265
-340,414
-182,051
-316,381
Net income available to common shareholders
-327,265
-327,265
-340,414
-182,051
-316,381
Basic EPS
-2.20
-
-2.38
-1.34
-2.63
Diluted EPS
-2.20
-
-2.38
-1.34
-2.63
Basic average shares
150,856
-
143,147
135,820
120,370
Diluted average shares
150,856
-
143,147
135,820
120,370
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.